Results 51 to 60 of about 7,810 (157)

Diagnostic Usefulness of Cell Block Samples in Fluid Overload‐Associated Large B‐Cell Lymphoma

Diagnostic Cytopathology, Volume 54, Issue 12, Page E308-E312, December 2026.
ABSTRACT Fluid overload‐associated B‐cell lymphoma (FO‐LBCL) is a B‐cell neoplasm that presents as serous effusions without detectable tumor masses and Kaposi sarcoma‐associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8) infection. Here, we report a case of an 81‐year‐old female patient with FO‐LBCL (Stage IVA) who presented with pericardial and ...
Hiroyuki Okanishi, Hiroko Kuwabara, Hiroko Nakayama, Mayo Odaka, Kozue Ariga, Isako Kataoka, Mari Tomiuka, Mayumi Uragami, Chihiro Deguchi, Shizuka Ono, Reika Takeda, Yoshitaka Kurisu, Yoshinobu Hirose, Yuuki Kinoshita, Taiji Yokote   +14 more
wiley   +1 more source

Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain

AIDS Research and Treatment, 2011
Since its discovery in 1994, Kaposi's sarcoma-associated herpesvirus (KSHV) has been associated with lymphoproliferative disorders, particularly in patients infected with human ...
Jason R. Andrews, Yoon Andrew Cho-Park, Judith Ferry, Jeremy S. Abramson, Gregory K. Robbins   +4 more
doaj   +1 more source

EBV‐Driven ODC1 Upregulation Enhances Polyamine Anabolism to Promote Viral Replication and Cisplatin Resistance in Nasopharyngeal Carcinoma

Advanced Science, Volume 13, Issue 61, 3 November 2026.
EBV‑BZLF1 initiates ODC1‑driven polyamine anabolism that correlates with poor clinical prognosis in nasopharyngeal carcinoma. The ODC1–spermidine axis promotes viral replication, cell proliferation and innate immune evasion. Pharmacological inhibition of ODC1 rescues cisplatin sensitivity, establishing ODC1 as a viable therapeutic target for EBV ...
Yueshuo Li, Xudong Hu, Chenxing Yang, Na Liu, Lin Wang, Xi Cai, Min Tang, Ya Cao, Li Shang, Feng Shi   +9 more
wiley   +1 more source

Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus [PDF]

Current Opinion in Oncology, 2007
To summarize major recent findings on the biology of human herpesvirus-8, i.e. Kaposi’s sarcoma-associated herpesvirus, and the implications of these findings for Kaposi’s sarcoma treatment.
Dirk P, Dittmer, Susan E, Krown
openaire   +2 more sources

HIV-negative disseminated Kaposi’s sarcoma in a Taiwanese patient

Kaohsiung Journal of Medical Sciences, 2011
Kaposi’s sarcoma is a common malignancy associated with HIV/AIDS. Herein, we describe the case of a 26-year-old man who presented with bilateral neck and inguinal lymphadenopathy, a massive tumor on the gum, and a nodule over the left eye.
Chiung-Tang Huang, Chao-Sung Chang, Hung-Chune Maa, Shih-Feng Cho, Ta-Chih Liu   +4 more
doaj   +1 more source

Epigenetic Regulation of Kaposi’s Sarcoma-Associated Herpesvirus Latency

Frontiers in Microbiology, 2020
Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic γ-herpesvirus that infects humans and exhibits a biphasic life cycle consisting of latent and lytic phases.
Mel Campbell, Wan-Shan Yang, Wayne W. Yeh, Chen-Hsuan Kao, Pei-Ching Chang   +4 more
doaj   +1 more source

Empagliflozin Modulates Apoptosis and Autophagy Pathways in Lung Cancer Through Network Pharmacology and In Vitro Analysis

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
An integrated computational and in vitro approach was used to investigate the anticancer activity of empagliflozin (EMPA) in A549 and HOP‐92 lung cancer cells and its interaction with hydroxychloroquine (HCQ). Network pharmacology identified 239 shared EMPA–lung cancer targets, while molecular docking predicted favorable interactions with ANXA8, SQSTM1/
Ola A. El‐Feky, Sara M. Hamouda, Manar Mohammed El Tabaa, Sally E. Abu‐Risha, Ahmed B. M. Mehany, Othman F. Abdelzaher, Samar A. El‐Adawy   +6 more
wiley   +1 more source

Kaposi‘s Sarcoma-Associated Herpesvirus and Innate Immunity [PDF]

Future Virology, 2010
Kaposi's sarcoma-associated herpesvirus (KSHV) is the most recently discovered human herpesvirus, first isolated and identified from a Kaposi's sarcoma lesion in 1994. It is the etiological agent of Kaposi's sarcoma, a vascular lesion that is the predominant cancer among AIDS patients. KSHV is also the primary etiological agent of two B-cell lymphomas,
John A, West, Blossom, Damania
openaire   +2 more sources

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin [PDF]

Journal of Virology, 1997
Kaposi's sarcoma-associated herpesvirus (KSHV) (also called human herpesvirus 8) is consistently found in Kaposi's sarcoma lesions and in body-cavity-based lymphomas. A 17-kb KSHV lambda clone was obtained directly from a Kaposi's sarcoma lesion. DNA sequence analysis of this clone identified an open reading frame which has 32% amino acid identity and ...
M, Li, H, Lee, D W, Yoon, J C, Albrecht, B, Fleckenstein, F, Neipel, J U, Jung   +6 more
openaire   +2 more sources

Unmasking the Influence of Viral Micro‐RNAs on Host Immunity

Immunology &Cell Biology, Volume 104, Issue 10, Page 964-974, November‐December 2026.
Viral micro‐RNAs are increasingly recognized as key modulators of host–virus interactions. They influence multiple immune functions, including antigen presentation, T‐cell activation, and cytokine signaling, while also tuning viral gene expression to promote persistence.
Riley J. K. Easton, Bernadette M. Saunders   +1 more
wiley   +1 more source